@xconomy.com 4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@techcrunch.com 8 years ago
Alphabet Gets A “V” By Renaming Google Life Sciences To “Verily”